Western blot analysis of the mTOR and STAT3 survival pathways showed a significant reduction in p‐mTOR and p‐STAT3 in both LP‐1 and XG‐2 multiple myeloma cells treated with propranolol (Figure 2G and supplementary material, Figure S2). The gene discussed is STAT3; the disease is plasma cell myeloma.